Published today, Ethical Considerations for Heart Organ Allocation: Current Landscape and Future Policy Iterations, a Scientific Statement from the American Heart Association.
There are 4 groups of decision-makers in transplantation. Each of these decision-makers has interests and motivations for participating in an organized allocation system, particularly in the setting of organ scarcity.
✍🏼 @KhazanieHeart@MarkDrazner@KBreathettMD@CohenProf@megfrasernp@KiranKhush1@JRogersMD1@laurentrubymd@P_StLaurent
Happy to share our paper in @JCardiacFailure 🫀
We found that when using POCUS of the internal jugular veins to estimate RAP in #HeartFailure, the right and left sides of the neck can tell different stories. @MarkDrazner
Here's what we learned 🧵https://t.co/hYUloj5Nmf
The future of #HFrEF treatment: can we move from a strategy of “Lifetime quadruple therapy for all” to “Personalized GDMT”? Congratulations to @UTSWMedCenter MS4 Michael Pitonak for leading this effort! @jtthib
“What brought you to heart failure?”
In this special episode, six HFSA past presidents share the defining moments, mentors, and clinical experiences that shaped their careers — from hemodynamics and early HF trials to transformative ICU care. Their reflections offer a rare look at how leaders in our field found purpose and direction.
Listen here: 🔗 https://t.co/AgeqbTCsp1
#HFBeat @nancy_m_albert@BiykemB@JamesCFangMD@MarkDrazner@DukeHFDoc@MHBeasleyMD@priyaumapathi
☄️According to 2025 NRMP match data, 38 (51%) AHFTC programs didn’t fill their programs with 51 (40%) unfilled positions
As the burden of 🫀HF increases and HF mortality rates ⬆️, we need the best and brightest in our field @EiranGorodeski@MKIttlesonMD@MarkDrazner@gcfmd
The physical exam changes & evolves but always remains critical to the clinical assessment of a patient. Check out our novel #POCUS protocol to assess volume status #jacchf@JACCJournals
�� https://t.co/uujYGEuO8p
Thrilled to share our paper in @JACCJournals
I had the honor of working with @MarkDrazner@JTThibs and our amazing team on a Novel, bedside 4-stage POCUS protocol to estimate RAP using internal jugular vein–carotid artery comparisons @HFSA
Pheochromocytoma is a rare cause of #NICM w/ variable clinical presentation. Dr. @MarkDrazner, et al report 2 cases in which Dx of pheochromocytoma was not initially recognized during evaluation of 📉 #LVEF, despite some potential clues https://t.co/5ywKU1WXnC #JACCCaseReports
Calling all Teachers & Mentors 🗣️: send us your perspectives on how YOU do things in Heart Failure care or at its many intersections! We want to share great nuggets from all of you 🫵 Master Clinicians and Educators! @HFSA@SocietyOfCCC@MarkDrazner@DukeHFDoc
3 Ways to Save on HFSA Membership 👇
❤️ First-time members get 50% off HFSA Membership
❤️ HFSA Members receive discounted ASM registration
❤️ ASM Early Bird registration is now open
Sign up for HFSA Membership before June 30 to take advantage of these benefits and more!
https://t.co/EDgcIX1QVK
Should we fluid restrict for patients who have HF? Are there particular patients for whom fluid restriction is or is not beneficial? Our own @MarkDrazner led an excellent discussion regarding these issues following the presentation of the LBCT: FRESH-UP at #ACC25. @utswheart@UTSWMedCenter@UTSWCardfellow